SHARP PHILLIP A 4
4 · ALNYLAM PHARMACEUTICALS, INC. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
SHARP PHILIP A
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2024-02-29$59.25/sh+30,000$1,777,500→ 30,000 total - Sale
Common Stock
[F1][F2]2024-02-29$150.60/sh−13,005$1,958,553→ 16,995 total - Sale
Common Stock
[F1][F3]2024-02-29$151.43/sh−13,557$2,052,937→ 3,438 total - Sale
Common Stock
[F1][F4]2024-02-29$152.40/sh−915$139,446→ 2,523 total - Sale
Common Stock
[F1][F5]2024-02-29$153.62/sh−1,906$292,800→ 617 total - Sale
Common Stock
[F1][F6]2024-02-29$154.07/sh−101$15,561→ 516 total - Sale
Common Stock
[F1][F7]2024-02-29$156.54/sh−516$80,775→ 0 total - Exercise/Conversion
Stock Option (right to buy)
[F1]2024-02-29−30,000→ 0 totalExercise: $59.25From: 2015-06-05Exp: 2024-06-04→ Common Stock (30,000 underlying)
Holdings
- 266,899(indirect: By Trust)
Common Stock
[F8]
Footnotes (8)
- [F1]The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2023. The 30,000 options exercised and sold by the reporting person were due to expire on June 4, 2024.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $150.00 to $151.00. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $151.01 to $151.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $152.02 to $152.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F5]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $153.04 to $154.03. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F6]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $154.06 to $154.99. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F7]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $156.15 to $156.98. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F8]Includes shares held by the Phillip A. Sharp Revocable Trust, of which the reporting person and his spouse are co-trustees. Also includes shares held in trust for the benefit of the reporting persons children, of which the reporting persons children and spouse are the trustees.
Signature
By: Stephen Hall, Attorney-in-Fact For: Phillip A. Sharp|2024-03-01